Roivant Sciences President and Chief Investment Officer Mayukh Sukhatme sold 1,000,000 shares on June 30, 2026. The total transaction value reached $34,105,000.
Sukhatme exercised options at a price of $3.85 per share. He sold the resulting shares at weighted average prices exceeding $34.
The sale follows Roivant’s removal from the Russell 1000 Value-Defensive and Russell 1000 Defensive Indexes in late June 2026.